Zolpidem Tartrate
Product Images NDC 0955-1702

4 FDA label images from Sanofi-aventis U.s. Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 0955-1702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zolpidem 01)

Chemical Structure (Zolpidem 01)
Chemical structure diagram of Zolpidem Tartrate showing the molecular arrangement of the active ingredient, including two molecular units connected with a tartrate moiety.*
FDA Label Image

Figure 1 (Zolpidem 02)

Figure 1 (Zolpidem 02)
A line graph comparing zolpidem plasma concentrations (ng/mL) over time (hours) for two forms: 12.5 mg Ambien-CR and 10 mg zolpidem tartrate Immediate release. The graph shows concentration peaks and declines across an 8-hour period with distinct curves for each form.*
FDA Label Image

Principal Display Panel (6.25 mg Tablet Bottle Label)

Principal Display Panel (6.25 mg Tablet Bottle Label)
Label for Zolpidem Tartrate Extended-Release 6.25 mg tablets by Sanofi-Aventis U.S. LLC, marketed under the Winthrop brand. The package contains 100 tablets with instructions to dispense with Medication Guide and a prescription only notice. Storage instructions and manufacturer details including Sanofi and Winthrop information are also visible.*
FDA Label Image

Principal Display Panel (12.5 mg Tablet Bottle Label)

Principal Display Panel (12.5 mg Tablet Bottle Label)
Label for Zolpidem Tartrate Extended-Release 12.5 mg tablets by Sanofi-Aventis U.S. LLC under the Winthrop brand. The label includes dosage strength, quantity of 100 tablets, storage instructions, NDC 0955-1703-10, and dispensing warnings including child-resistant packaging and medication guide requirements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.